USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HOPE PHARMACEUTICALS
Address:
HOPE PHARMACEUTICALS
16416 N. 92nd Street #125
SCOTTSDALE, AZ
Phone:
N/A
URL:
N/A
EIN:
133044756
DUNS:
15227945
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,136,424.00 2

Award List:

Prevention of Delayed Cerebral Vasospasm Associated with Subarachnoid Hemorrhage

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$1,899,507.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Hope Pharmaceuticals (Hope) is a Small Business that distributes a limited line of proprietary pharmaceuticals. In 2007, Hope licensed from the National Institutes of Health (NIH) exclusive, worldwide rights to two pend ing patent applications for recently… More

Prevention of ischemia reperfusion injury associated with acute myocardial infarc

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$236,917.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Hope Pharmaceuticals is a small business that distributes Sodium Nitrite Injection and owns patent rights to a recently discovered use for sodium nitrite as a means to prevent ischemia-reperfusion injury. Ischemia-repe rfusion injury refers to tissue damage… More